ArticleAIDS (London, England)2017

Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.

Thomas A Rasmussen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.